← All trials
NCT02748798
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2016
- Primary completion
- Jun 1, 2018
- Completion date
- Jun 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 160
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Northern Ontario School of MedicineLead sponsor
- Northern Ontario School of MedicineOverall official - principal investigator
- Northern Ontario School of MedicineCollaborator
- Lakehead UniversityCollaborator
- University of Western OntarioCollaborator
Drugs studied
Indications studied
- Allergy and Immunology
- Asbestosis
- Asthma
- Bronchiectasis
- Bronchopulmonary Dysplasia
- Common Cold
- Cystic Fibrosis
- Emphysema
- Hypertension, Pulmonary
- Lung
- Lung Neoplasms
- Mesothelioma
- Pulmonary Embolism
- Pulmonary Fibrosis
- Respiratory Tract Infections
- Lung Transplantation
- Lung Diseases, Interstitial
- Sleep Apnea, Obstructive
- Pulmonary Disease, Chronic Obstructive
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.